RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2020

Feb 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2020-02-10

Reporting Person: Gottesdiener Keith Michael (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-10	Common Stock	M	6816	$6.14	Acquired	554283	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-10	Employee Stock Option (Right to Buy)	$6.14	M	6816	Disposed	2027-04-04	Common Stock (6816)	Direct

Footnotes

F1: Includes 553 shares acquired under the issuer's 2017 Employee stock purchase plan on September 3, 2019.

F2: The stock options vest and become exercisable in 48 successive, equal monthly installments measured from January 6, 2017.